Detection of Gliadin‐Activated CD4 + T Cells Is a New Assay to Reveal Pathogenic Lymphocytes in Celiac Disease
Journal of Cellular and Molecular Medicine · 2025-10 · 29 (20)
DOI: 10.1111/jcmm.70898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 22.10.2025. Verfasst von Laura Pisapia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetics and Biophysics, CNR, Naples, Italy. Hauptthemen laut MEDLINE: Celiac Disease, Gliadin, CD4-Positive T-Lymphocytes, Lymphocyte Activation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consiglio Nazionale delle Ricerche.
Abstract (Originalsprache)
The diagnosis of celiac disease (CD) relies on the presence of serum antibodies against type 2‐tissue transglutaminase (tTG2) and endomysium, which in adult patients must be confirmed by assessing small intestinal mucosa damage through esophagogastroduodenoscopy. We aim to establish a non‐invasive method focused on detecting activated CD4 + T cells that are reactive to gliadin in the peripheral blood of patients with untreated CD. Peripheral blood mononuclear cells from 20 patients with untreated CD, 17 patients on a gluten‐free diet and 10 healthy donors were stimulated in vitro with whole gliadin or immunodominant peptides. After 48 h, cells were stained with fluorochrome‐conjugated monoclonal antibodies against OX40 and 4‐1BB surface activation markers. Gliadin‐specific, activated CD4 + T cells were detected through multiparametric flow cytometry. OX40 and 4‐1BB activation markers are upregulated on CD4 + T cells following the engagement of the HLA‐DQ2.5‐gliadin complex with the T‐cell receptor (TCR). The frequency of gliadin‐specific, CD3 + /CD4 + /OX40 + /4‐1BB + cells is significantly higher in untreated than in treated patients and healthy controls and shows a positive correlation with the anti‐tTG2 antibody titers. This assay, defined as the G.A.T.CD4 ( Gliadin activated CD4 + T cells ) method, might support CD diagnosis, particularly in doubtful cases having low autoantibody serum titers. G.A.T.CD4 can be of help in monitoring disease progression, as the pathogenic T cells expressing OX40 and 4‐1BB activation markers are undetectable in the blood of treated patients. In the future, we aim to propose the G.A.T.CD4 instead of esophagogastroduodenoscopy to perform accurate and less invasive diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genetics and Biophysics, CNR, Naples, Italy.
- Institute of Biochemistry and Cell Biology, CNR, Naples, Italy.
- Institute of Endotypes in Oncology, Metabolism and Immunology "G. Salvatore", CNR, Naples, Italy.
- Department of Molecular Medicine and Medical Biotechnology, CEINGE Advanced Biotechnologies "Franco Salvatore", Naples, Italy.
- Gastroenterology, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
ORCID-Profile: Giovanna Del Pozzo
Förderung
- Consiglio Nazionale delle Ricerche
Zitieren
APA
Pisapia, L., D'Ambrosio, M., Mottola, I., Picascia, S., De Girolamo, D., Castiglione, F., Tinto, N., Rispo, A., Gianfrani, C., & Del Pozzo, G. (2025). Detection of Gliadin‐Activated CD4 + T Cells Is a New Assay to Reveal Pathogenic Lymphocytes in Celiac Disease. Journal of Cellular and Molecular Medicine, 29(20). https://doi.org/10.1111/jcmm.70898
Vancouver
Pisapia L, D'Ambrosio M, Mottola I, Picascia S, De Girolamo D, Castiglione F, et al. Detection of Gliadin‐Activated CD4 + T Cells Is a New Assay to Reveal Pathogenic Lymphocytes in Celiac Disease. Journal of Cellular and Molecular Medicine. 2025;29(20). doi:10.1111/jcmm.70898
BibTeX
@article{Pisapia2025,
author = {Pisapia, Laura and D'Ambrosio, Marcella and Mottola, Ilaria and Picascia, Stefania and De Girolamo, Domenico and Castiglione, Fabiana and Tinto, Nadia and Rispo, Antonio and Gianfrani, Carmen and Del Pozzo, Giovanna},
title = {Detection of Gliadin‐Activated CD4 + T Cells Is a New Assay to Reveal Pathogenic Lymphocytes in Celiac Disease},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {20},
doi = {10.1111/jcmm.70898}
}
EUVIMED